NEW YORK (Reuters) - Wall Street closed little changed in light trading on Monday as consumer discretionary gains countered losses in energy shares and investors laid low ahead of a U.S. Federal Reserve meeting.
The Fed is not expected to raise interest rates at the two-day meeting, which begins on Tuesday, but investors will be on the lookout for clues about future hikes.
“If investors are inclined to make a bet, then they’re better served by waiting a few days,” said Jack Ablin, chief investment officer at BMO Private Bank in Chicago.
Global oil prices fell as much as 4 percent on concerns a six-week market recovery has gone beyond fundamentals.
The recent rally in oil prices and data pointing to a strengthening U.S. economy have helped stocks recover from a steep selloff at the start of the year.
The S&P 500 is now down about 1 percent in 2016, after having been down as much as 10.5 percent in mid-February.
As they also wait on the release of economic data, including U.S. retail sales, investors were further digesting moves by the European Central Bank and other global economic news last week.
“To me, it’s one of those days where the market is doing its best to digest some of those factors and to see what’s next,” said Steven Baffico, chief executive officer at Four Wood Capital Partners in New York.
The Dow Jones industrial average .DJI closed up 15.82 points, or 0.09 percent, to 17,229.13, the S&P 500 .SPX lost 2.55 points, or 0.13 percent, to 2,019.64 and the Nasdaq Composite .IXIC added 1.81 points, or 0.04 percent, to 4,750.28.
Seven of the 10 major S&P sectors were lower. The energy sector .SPNY fell 0.6 percent. Schlumberger's SLB.N 2.1-percent fall and Baker Hughes' BHI.N 4.2-percent decline weighed the most on the sector.
The consumer discretionary sector .SPLRCD rose 0.4 percent.
Starwood Hotels & Resorts HOT.N climbed 7.8 percent at $75.93 after the hotel operator received a takeover offer of $76 per share from a consortium of companies. Marriott MAR.O, which had been set to take over Starwood, ended up 3 percent at $70.93.
GW Pharmaceuticals GWPH.O soared 120 percent to $84.71. The company's experimental cannabis-based drug succeeded in treating children with a rare form of severe epilepsy.
About 6.3 billion shares changed hands in U.S. exchanges, below the 8.3 billion average over the last 20 sessions and the lowest daily volume of the year.
Declining issues outnumbered advancing ones on the NYSE by 1,679 to 1,311, for a 1.28-to-1 ratio on the downside; on the Nasdaq, 1,507 issues fell and 1,276 advanced for a 1.18-to-1 ratio favoring decliners.
The S&P 500 posted 12 new 52-week highs and no new lows; the Nasdaq recorded 40 new highs and 20 new lows.
Additional reporting by Abhiram Nandakumar in Bengaluru; Editing by Meredith Mazzilli and Nick Zieminski
Our Standards: The Thomson Reuters Trust Principles.